Abel Hall LLC’s Merck MRK Stock Holding History

Abel Hall LLC’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1M	Sell	7,789 -8,120	-51%	-$950K	0.17%	83
2026 Q1	$1.91M	Buy	15,909 +4,520	+40%	+$522K	0.41%	32
2025 Q4	$1.2M	Buy	11,389 +966	+9%	+$90.7K	0.28%	47
2025 Q3	$875K	Sell	10,423 -47	-0.4%	-$3.87K	0.35%	41
2025 Q2	$829K	Buy	10,470 +2,451	+31%	+$195K	0.38%	41
2025 Q1	$720K	Buy	8,019 +3,005	+60%	+$281K	0.43%	36
2024 Q4	$499K	Sell	5,014 -242	-5%	-$24.9K	0.32%	45
2024 Q3	$597K	Sell	5,256 -5	-0.1%	-$594	0.39%	39
2024 Q2	$651K	Buy	5,261 +162	+3%	+$20.9K	0.46%	36
2024 Q1	$673K	Buy	5,099 +87	+2%	+$10.7K	0.5%	33
2023 Q4	$546K	Buy	+5,012	New	+$520K	0.47%	32

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Abel Hall LLC's MRK Position: Q2 2026 in Review

Abel Hall LLC reduced its Merck (MRK) stake by 51% in Q2 2026, selling an estimated $950K and leaving 7,789 shares worth $1M. The position accounts for 0.17% of the portfolio, ranked #83.

Abel Hall LLC first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.91M in Q1 2026. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Abel Hall LLC held 7,789 shares of Merck worth $1M as of Q2 2026.
Abel Hall LLC sold 8,120 Merck shares in Q2 2026, an estimated $950K.
Merck made up 0.17% of Abel Hall LLC's portfolio in Q2 2026, its #83 holding.
Abel Hall LLC first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
Abel Hall LLC's Merck position peaked at $1.91M in Q1 2026.
1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.